Wow. Lenacapavir, a twice-yearly shot that prevents HIV spread was just approved by the FDA.
The problem? Due to government cuts to Medicaid, PEPFAR, and Global Fund, it's unlikely this game-changing drug will reach the many people who need it most in the US and globally.